Page last updated: 2024-08-17

levodopa and Cancer of Skin

levodopa has been researched along with Cancer of Skin in 45 studies

Research

Studies (45)

Timeframe	Studies, this research(%)	All Research%
pre-1990	20 (44.44)	18.7374
1990's	10 (22.22)	18.2507
2000's	11 (24.44)	29.6817
2010's	2 (4.44)	24.3611
2020's	2 (4.44)	2.80

Authors

Authors	Studies
Guillén Climent, S; Monteagudo, C; Pinazo Canales, MI; Porcar Saura, S	1
Cardoso, R; da S Gonçalves Vianez, JL; de Molfetta, FA; Nahum Alves, C; Santana da Costa, K; Souza da Costa, CH; Valente, R	1
Disse, M; Lee, PK; Reich, H; Schram, SS	1
Trip, J; Vermeij, JD; Weber, WE; Winogrodzka, A	1
Charles, J; Lantuejoul, S; Leccia, MT; Leroux, D; Robert, C; Salameire, D; Templier, I	1
Inzelberg, R; Israeli-Korn, SD	1
Pawelek, J; Slominski, A; Zmijewski, MA	1
Bonenkamp, JJ; Wobbes, T	1
Bousquet, B; Garnier, JP; Ghanem, G; Le Bricon, T; Letellier, S; Morel, P; Stoitchkov, K; Tsankov, N	1
Fiala, KH; Manyam, BV; Whetteckey, J	1
Loria, D; Rosso, S; Zanetti, R	1
Bressac de Paillerets, B; Charles, J; Combe, MC; Leccia, MT; Leroux, D; Templier, I	1
Baccard, M; Basset-Seguin, N; Bousquet, B; Cassinat, B; Dubertret, L; Garnier, JP; Kerob, D; Le Bricon, T; Lebbé, C; Letellier, S; Morel, P; Stoitchkov, K	1
Constantinescu, R; Kieburtz, K; Romer, M	1
Fitzpatrick, TB; Harrist, TJ; Melski, JW; Mihm, MC; Rhodes, AR; Sober, AJ	1
Lukács, L; Menyhei, G; Péter, S	1
Braun, M; Rosin, MA	1
Wick, MM	3
Gilbert, EF; Ramirez, G; Warner, TF	1
Bernstein, JE; Lorincz, AL; Medenica, M; Solomon, A; Soltani, K	1
Goldenberg, JN; Sanchez-Ramos, JR; Singer, C; Weiner, WJ	1
Burg, G; Kleinhans, M; Schmid-Grendelmeier, P	1
Pfützner, W; Przybilla, B	1
Bousquet, B; Garnier, JP; Letellier, S; Spy, J	1
Rampen, F	1
Baccard, M; Bousquet, B; Garnier, JP; Kerneis, Y; Le Bricon, T; Letellier, S; Revol, M; Spy, J; Stoitchkov, K	1
Dizdar, N; Granérus, AK; Hannestad, U; Kågedal, B; Kullman, A; Ljungdahl, A; Olsson, JE	1
Botha, R; Chen, S; Reuhl, K; Ryan, K; Wei, J; Zhu, H	1
Delaney, P; Fermaglich, J	2
Busse, E; Riessbeck, KH; Rose, H	1
Sober, AJ; Wick, MM	1
Maat, B	1
Pelfréne, AF	1
Esteguy, M; Leiguarda, R; Merello, M; Perazzo, F	1
D'iakov, VL; Iakh''iaev, AV; Lalaev, VV; Sukhanov, VA	1
Coates, A; Gurney, H; Kefford, R	1
Kande'l, EI	1
Maggini, M; Morpurgo, G	1
Camp, VM; Faraj, BA; Hearn, J; Kutner, M; Murray, DR; Nixon, D	1
Rampen, FH	1
Kochar, AS	1

Reviews

10 review(s) available for levodopa and Cancer of Skin

Article	Year
A Review of the Association Between Parkinson Disease and Malignant Melanoma. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2016, Volume: 42, Issue:2 Topics: Antiparkinson Agents; Environment; Genetic Predisposition to Disease; Humans; Levodopa; Melanoma; Parkinson Disease; Risk Factors; Skin Neoplasms; Skin Pigmentation	2016
Parkinson's disease, levodopa-use and the risk of melanoma. Parkinsonism & related disorders, 2009, Volume: 15, Issue:8 Topics: Animals; Humans; Levodopa; Melanoma; Parkinson Disease; Risk Factors; Skin Neoplasms	2009
The particular relationship between Parkinson's disease and malignancy: a focus on skin cancers. Journal of neural transmission (Vienna, Austria : 1996), 2009, Volume: 116, Issue:11 Topics: Antiparkinson Agents; Causality; Comorbidity; Humans; Levodopa; Mass Screening; Melanoma; Parkinson Disease; Risk Factors; Skin Neoplasms	2009
L-tyrosine and L-dihydroxyphenylalanine as hormone-like regulators of melanocyte functions. Pigment cell & melanoma research, 2012, Volume: 25, Issue:1 Topics: Animals; Humans; Levodopa; Melanins; Melanocytes; Melanoma; Models, Biological; Monophenol Monooxygenase; Oxidative Stress; Skin Neoplasms; Structure-Activity Relationship; Tyrosine	2012
Malignant melanoma and levodopa in Parkinson's disease: causality or coincidence? Parkinsonism & related disorders, 2003, Volume: 9, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Female; Humans; Levodopa; Male; Melanoma; Middle Aged; Parkinson Disease; Retrospective Studies; Skin Neoplasms	2003
Melanoma, Parkinson's disease and levodopa: causal or spurious link? A review of the literature. Melanoma research, 2006, Volume: 16, Issue:3 Topics: Animals; Humans; Levodopa; Melanoma; Mice; Parkinson Disease; Skin Neoplasms	2006
Levodopa, melanoma, and Parkinson's disease. Neurology, 1993, Volume: 43, Issue:4 Topics: Adult; Aged; Antiparkinson Agents; Contraindications; Female; Follow-Up Studies; Humans; Levodopa; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Parkinson Disease; Skin Neoplasms	1993
[Levodopa and malignant melanoma--case report and review of the literature. A contribution to causal relationship between levodopa and the development of malignant melanoma]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1996, Volume: 47, Issue:6 Topics: Aged; Antiparkinson Agents; Cell Transformation, Neoplastic; Humans; Levodopa; Long-Term Care; Male; Melanoma; Parkinson Disease; Skin; Skin Neoplasms	1996
Malignant melanoma and levodopa: is there a relationship? Two new cases and a review of the literature. Journal of the American Academy of Dermatology, 1997, Volume: 37, Issue:2 Pt 2 Topics: Aged; Antiparkinson Agents; Back; Biopsy; Humans; Levodopa; Male; Melanoma; Middle Aged; Nose Neoplasms; Parkinson Disease; Skin; Skin Neoplasms	1997
[Melanoma as a possible complication of the treatment of parkinsonism with L-dopa preparations (review of the literature)]. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1989, Volume: 89, Issue:9 Topics: Humans; Levodopa; Melanoma; Parkinson Disease; Skin Neoplasms	1989

Other Studies

35 other study(ies) available for levodopa and Cancer of Skin

Article	Year
Melanocytic Hyperactivation Simulating an Acral Lentiginous Melanoma in a Patient With Parkinson Disease Treated by Levodopa. The American Journal of dermatopathology, 2021, Mar-01, Volume: 43, Issue:3 Topics: Aged; Antiparkinson Agents; Carbidopa; Diagnosis, Differential; Drug Combinations; Female; Humans; Hyperpigmentation; Levodopa; Melanins; Melanocytes; Melanoma; Parkinson Disease; Predictive Value of Tests; Skin; Skin Neoplasms; Skin Pigmentation; Treatment Outcome	2021
Analysis of Kojic Acid Derivatives as Competitive Inhibitors of Tyrosinase: A Molecular Modeling Approach. Molecules (Basel, Switzerland), 2021, May-12, Volume: 26, Issue:10 Topics: Catalytic Domain; Enzyme Inhibitors; Humans; Levodopa; Melanins; Melanocytes; Melanoma; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Monophenol Monooxygenase; Pyrones; Skin Neoplasms; Structure-Activity Relationship; Tyrosine	2021
Twenty-two cutaneous primary melanomas in a patient with high genetic predisposition to melanoma receiving levodopa therapy for Parkinson's disease. Pigment cell & melanoma research, 2009, Volume: 22, Issue:6 Topics: DNA Mutational Analysis; Genetic Predisposition to Disease; Humans; Levodopa; Male; Melanoma; Middle Aged; Parkinson Disease; Skin Neoplasms; Ultraviolet Rays	2009
[Melanoma while using levodopa due to Parkinson's disease--causal association unlikely]. Nederlands tijdschrift voor geneeskunde, 2002, Jul-06, Volume: 146, Issue:27 Topics: Aged; Antiparkinson Agents; Chemotherapy, Cancer, Regional Perfusion; Female; Humans; Leg; Levodopa; Lymph Node Excision; Lymphatic Metastasis; Melanins; Melanoma, Amelanotic; Parkinson Disease; Skin Neoplasms	2002
Melanoma progression and serum L-dopa/L-tyrosine ratio: a comparison with S100B. Melanoma research, 2002, Volume: 12, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Bulgaria; Chromatography, High Pressure Liquid; Disease Progression; Female; Follow-Up Studies; Humans; Levodopa; Male; Melanoma; Middle Aged; Neoplasm Proteins; Neoplasm Staging; Nerve Growth Factors; Predictive Value of Tests; Prognosis; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Skin Neoplasms; Tyrosine	2002
[CDKN2A gene mutation and loss of p16 protein activity in a patient on levodopa presenting sporadic multiple primary melanoma]. Annales de dermatologie et de venereologie, 2006, Volume: 133, Issue:10 Topics: Antiparkinson Agents; Cyclin-Dependent Kinase Inhibitor p16; Genes, p16; Humans; Levodopa; Male; Melanoma; Middle Aged; Mutation; Skin Neoplasms	2006
Clinical value of combined determination of plasma L-DOPA/tyrosine ratio, S100B, MIA and LDH in melanoma. European journal of cancer (Oxford, England : 1990), 2007, Volume: 43, Issue:4 Topics: Aged; Antigens, Tumor-Associated, Carbohydrate; Biomarkers, Tumor; Female; Humans; Levodopa; Male; Melanoma; Middle Aged; Prospective Studies; S100 Proteins; Sensitivity and Specificity; Skin Neoplasms; Survival Analysis; Tyrosine	2007
Malignant melanoma in early Parkinson's disease: the DATATOP trial. Movement disorders : official journal of the Movement Disorder Society, 2007, Apr-15, Volume: 22, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Cohort Studies; Comorbidity; Cross-Sectional Studies; Female; Humans; Incidence; Levodopa; Male; Melanoma; Middle Aged; Multicenter Studies as Topic; Parkinson Disease; Randomized Controlled Trials as Topic; Reference Values; Retrospective Studies; Skin Neoplasms	2007
Increased intraepidermal melanocyte frequency and size in dysplastic melanocytic nevi and cutaneous melanoma. A comparative quantitative study of dysplastic melanocytic nevi, superficial spreading melanoma, nevocellular nevi, and solar lentigines. The Journal of investigative dermatology, 1983, Volume: 80, Issue:5 Topics: Adult; Aged; Female; Histological Techniques; Humans; Lentigo; Levodopa; Male; Melanocytes; Melanoma; Middle Aged; Nevus; Paraffin; Skin; Skin Neoplasms	1983
[Serum L-DOPA oxidase activity in patients with malignant cutaneous melanoma]. Orvosi hetilap, 1984, Oct-07, Volume: 125, Issue:41 Topics: Adult; Female; Humans; Levodopa; Male; Melanoma; Middle Aged; Oxidoreductases; Skin Neoplasms	1984
Malignant melanoma and levodopa. Cutis, 1984, Volume: 33, Issue:6 Topics: Humans; Levodopa; Male; Melanins; Melanoma; Middle Aged; Neoplasms, Multiple Primary; Nevus; Skin Neoplasms	1984
The chemotherapy of malignant melanoma. The Journal of investigative dermatology, 1983, Volume: 80 Suppl Topics: Carbidopa; Cardiovascular Diseases; Dopamine; Drug Evaluation; Humans; Levodopa; Melanoma; Mitotic Index; Skin Neoplasms	1983
An experimental approach to the chemotherapy of melanoma. The Journal of investigative dermatology, 1980, Volume: 74, Issue:2 Topics: Antineoplastic Agents; Dopamine; Humans; Indoles; Levodopa; Melanins; Melanoma; Skin Neoplasms; Tyrosine	1980
Epidermotropism in melanoma. Journal of cutaneous pathology, 1980, Volume: 7, Issue:1 Topics: Epidermis; Humans; Levodopa; Male; Melanoma; Middle Aged; Neoplasms, Multiple Primary; Nevus; Skin; Skin Neoplasms; Time Factors	1980
Levodopa administration and multiple primary cutaneous melanomas. Archives of dermatology, 1980, Volume: 116, Issue:9 Topics: Aged; Female; Humans; Levodopa; Melanoma; Neoplasms, Multiple Primary; Skin Neoplasms; Tremor	1980
Determination of the L-DOPA/L-tyrosine ratio in human plasma by high-performance liquid chromatography. Usefulness as a marker in metastatic malignant melanoma. Journal of chromatography. B, Biomedical sciences and applications, 1997, Aug-15, Volume: 696, Issue:1 Topics: Biomarkers, Tumor; Calibration; Chromatography, High Pressure Liquid; Circadian Rhythm; Humans; Hydrogen-Ion Concentration; Levodopa; Linear Models; Melanins; Melanoma; Reproducibility of Results; Skin Neoplasms; Spectrometry, Fluorescence; Tyrosine	1997
Melanoma and levodopa. Journal of the American Academy of Dermatology, 1998, Volume: 38, Issue:5 Pt 1 Topics: Antiparkinson Agents; Dopamine Agonists; Humans; Levodopa; Melanoma; Parkinson Disease; Risk Factors; Skin Neoplasms	1998
Development of metastases in malignant melanoma is associated with an increase in the plasma L-dopa/L-tyrosine ratio. Melanoma research, 1999, Volume: 9, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Chromatography, High Pressure Liquid; Female; Follow-Up Studies; Humans; Levodopa; Longitudinal Studies; Male; Melanoma; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Reference Values; Skin Neoplasms; Tyrosine	1999
L-dopa pharmacokinetics studied with microdialysis in patients with Parkinson's disease and a history of malignant melanoma. Acta neurologica Scandinavica, 1999, Volume: 100, Issue:4 Topics: Aged; Antiparkinson Agents; Benserazide; Female; Humans; Levodopa; Male; Melanoma; Microdialysis; Middle Aged; Parkinson Disease; Skin Neoplasms	1999
Development of early melanocytic lesions in transgenic mice predisposed to melanoma. Pigment cell research, 2000, Volume: 13, Issue:3 Topics: Animals; Animals, Newborn; Anus Neoplasms; Ear Neoplasms; Eyelid Neoplasms; Genetic Predisposition to Disease; Levodopa; Melanocytes; Melanoma, Experimental; Mice; Mice, Transgenic; Neural Crest; Skin Neoplasms	2000
Parkinson's disease, melanoma, and levodopa. Journal of neurology, 1977, Jun-13, Volume: 215, Issue:3 Topics: Aged; Humans; Levodopa; Male; Melanoma; Parkinson Disease; Skin Neoplasms	1977
Changes in mouse skin cyclic nucleotides during chemical carcinogenesis and tumor response to treatment with BCG, L-Dopa and cyclic DBAMP. Journal of cancer research and clinical oncology, 1979, Jun-08, Volume: 94, Issue:2 Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; BCG Vaccine; Bucladesine; Cyclic AMP; Levodopa; Male; Mice; Mice, Inbred ICR; Mice, Inbred Strains; Neoplasm Recurrence, Local; Neoplasms, Experimental; Skin Neoplasms	1979
Levodopa therapy and malignant melanoma. JAMA, 1978, Aug-11, Volume: 240, Issue:6 Topics: Adult; Age Factors; Aged; Humans; Levodopa; Male; Melanoma; Middle Aged; Parkinson Disease; Skin Neoplasms	1978
Levodopa and melanoma. JAMA, 1979, Mar-02, Volume: 241, Issue:9 Topics: Humans; Levodopa; Melanoma; Parkinson Disease; Skin Neoplasms	1979
Pigmented hyperplasia of epidermis following feeding of L-dopa to elderly rats. Journal of the National Cancer Institute, 1977, Volume: 58, Issue:5 Topics: Age Factors; Animals; Humans; Hyperplasia; Levodopa; Male; Melanins; Melanoma; Neoplasms, Experimental; Pigmentation; Precancerous Conditions; Rats; Rats, Inbred BN; Recurrence; Skin; Skin Neoplasms	1977
[Letter: Malignant melanoma during treatment with levodopa]. La Nouvelle presse medicale, 1975, May-03, Volume: 4, Issue:18 Topics: Aged; Biopsy; Humans; Levodopa; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Parkinson Disease, Secondary; Skin Neoplasms	1975
Impaired levodopa response in Parkinson's disease during melanoma therapy. Clinical neuropharmacology, 1992, Volume: 15, Issue:1 Topics: Adult; Dacarbazine; Dopamine; Drug Interactions; Humans; Levodopa; Male; Melanins; Melanoma; Parkinson Disease; Skin Neoplasms	1992
[Heterogeneity of tyrosinases isolated from rat skin, normal human skin, and human melanoma tumors]. Biokhimiia (Moscow, Russia), 1991, Volume: 56, Issue:6 Topics: Animals; Blotting, Western; Chromatography, Liquid; Electrophoresis, Polyacrylamide Gel; Humans; Isoelectric Focusing; Isoenzymes; Kinetics; Levodopa; Melanoma; Monophenol Monooxygenase; Oxidation-Reduction; Rats; Skin; Skin Neoplasms	1991
The use of L-dopa and carbidopa in metastatic malignant melanoma. The Journal of investigative dermatology, 1991, Volume: 96, Issue:1 Topics: Carbidopa; Female; Humans; Levodopa; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Skin Neoplasms	1991
Levodopa/dopamine analogs as inhibitors of DNA synthesis in human melanoma cells. The Journal of investigative dermatology, 1989, Volume: 92, Issue:5 Suppl Topics: Animals; DNA; Dopamine; Dose-Response Relationship, Drug; Humans; Levodopa; Melanocytes; Melanoma; Mice; Skin Neoplasms	1989
A hypothesis on the etiology of malignant melanoma: the role of chemicals interfering with melanin synthesis. European journal of cancer & clinical oncology, 1987, Volume: 23, Issue:8 Topics: 9,10-Dimethyl-1,2-benzanthracene; Female; Humans; Levodopa; Male; Melanoma; Occupational Diseases; Polychlorinated Biphenyls; Skin Neoplasms; Sunlight	1987
Plasma L-dopa in the diagnosis of malignant melanoma. Clinical chemistry, 1986, Volume: 32, Issue:1 Pt 1 Topics: Adult; Aged; Female; Follow-Up Studies; Humans; Levodopa; Male; Melanoma; Middle Aged; Neoplasm Staging; Skin Neoplasms	1986
Levodopa and melanoma: three cases and review of literature. Journal of neurology, neurosurgery, and psychiatry, 1985, Volume: 48, Issue:6 Topics: Aged; Female; Humans; Levodopa; Male; Melanoma; Parkinson Disease; Skin Neoplasms	1985
Development of malignant melanoma after levodopa therapy for Parkinson's disease. Report of a case and review of the literature. The American journal of medicine, 1985, Volume: 79, Issue:1 Topics: Female; Humans; Levodopa; Melanoma; Middle Aged; Nevus, Pigmented; Parkinson Disease; Skin Neoplasms	1985
[Malignant melanoma and L-dopa. Review of literature on the problem of causal relationship]. Fortschritte der Medizin, 1974, Sep-26, Volume: 92, Issue:27 Topics: Humans; Levodopa; Male; Melanins; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Parkinson Disease; Skin Neoplasms; Tryptophan	1974